congenital afibrinogenemia rare genetically inherited blood fibrinogen disorder blood clot normally due lack fibrinogen blood protein necessary disorder autosomal recessive meaning two unaffected parents child lack fibrinogen expresses excessive times uncontrollable disorder present individual birth warning signs look first symptom usually seen hemorrhage umbilical cord difficult symptoms spontaneous bleeding mouth nose gastrointestinal tract common since blood clots formed minor injuries tend lead excessive bleeding bruising biggest concern individuals afibrinogenemia cns hemorrhage bleeding brain fatal many symptoms chronic continue occur entirety affected individuals lifecitation needed missense nonsense mutation genes code fibrinogen protein affected usually mutation leads early stop production due problem genetically based way prevent disease individuals get genetic testing done see carrier trait may choose complete genetic counseling better understand disorder help manage family planning parents choose prenatal genetic testing disorder determine child risk factor parents child carry recessive allele linked disordercitation needed individuals disorder mutation fibrinogen gene prevents formation normal conditions fibrinogen converted fibrin cleaved enzyme thrombin blood newly formed fibrin forms fiberrich network helps trap red blood cells start coagulation process form since fibrinogen present afibrinogenemia fibrin formed aid processcitation needed problem fibrinogen suspected following tests ordered blood fibrinogen levels less gl prolonged bleeding test times indicators individual suspicion congenital afibrinogenemia may appear platelet aggregation function test common treatment fibrinogen replacement therapy including cryoprecipitate blood plasma fibrinogen concentration transfusions help bleeding episodes prior although thrombotic complications reported following replacement therapy transfusions fibrinogen concentrate widely considered beneficial fibrinogen concentrate pure contains known quantity fibrinogen virally inactivated transfused small amounts lower chance allergic reaction response transfusion alternatively cryoprecipitate contains coagulation factors factors viii xiii von willebrand factor known cures forms holistic care date complications arise symptoms much data life expectancy individual afibrinogenemia difficult determine average lifespan however leading cause death thus far linked cns hemorrhage postoperative first described german doctors fritz rabe eugene salomon studying bleeding disorder presenting child disorder may also simply called afibrinogenemia familial million individuals diagnosed disease typically males females seem affected higher occurrence regions consanguinity currently research based pharmacological case seen congenital afibrinogenemia resolved patient receiving liver httpsenwikipediaorgwikicongenitalafibrinogenemia